Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > SEC Filings Onership
View:
Post by FarmerBetsy on Nov 07, 2024 9:27am

SEC Filings Onership

New ownership filings Michael Gordon 14%, Jeremy Sclar 19.1%.
Comment by goldtech on Nov 07, 2024 8:40pm
That's perfect because they will not sell this company for peanuts and I am sure they are watching the financials closely. I just wish they would get rid of Williams and most of the BOD.
Comment by FarmerBetsy on Nov 08, 2024 9:18am
The case by some could be made that the company has already sold cheaply to a few billionaires who hold majority of the shares. No poster yet? Phase 1 with healthy volunteers was the blood testing done by Promis?
Comment by Gbathat on Nov 07, 2024 10:34pm
Good news- thanks for sharing.
ProMIS Neurosciences Inc